Your browser doesn't support javascript.
loading
A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia.
Tsukada, Hironobu; Milanovic, Snezana M; Darpo, Borje; Xue, Hongqi; Xiong, Kuangnan; Tripp, Emily; Lennek, Lisa; Worden, MaryAlice; Hopkins, Seth C; Galluppi, Gerald R.
Afiliação
  • Tsukada H; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Milanovic SM; Sumitomo Pharma Co., Ltd., Tokyo, Japan.
  • Darpo B; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Xue H; Clario, Rochester, New York, USA.
  • Xiong K; Clario, Rochester, New York, USA.
  • Tripp E; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Lennek L; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Worden M; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Hopkins SC; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
  • Galluppi GR; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA.
Clin Transl Sci ; 16(6): 1063-1074, 2023 06.
Article em En | MEDLINE | ID: mdl-36949248

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Fluoroquinolonas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Fluoroquinolonas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article